1 / 4

China Indapamide Market Trends, Size, Forecast - 2020-2026

<br>China indapamide market is estimated to grow at a CAGR of around 4.1% during the forecast period. The market is mainly driven due to growing various heart-related diseases and other diseases in the country. Lack of physical activity, obese population, alcohol consumption, unhealthy diet, and smoking are some major factors leading to the rising number of incidences of these conditions. The rising aging population may further increase the risk of hypertension in China.<br>

pooja99
Download Presentation

China Indapamide Market Trends, Size, Forecast - 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research China Indapamide Market Trends, Size, Forecast - 2020-2026 Request a free sample of our report on China Indapamide Market: https://www.omrglobal.com/request-sample/china-indapamide-market ------------------------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. China indapamide market is estimated to grow at a CAGR of around 4.1% during the forecast period. The market is mainly driven due to growing various heart-related diseases and other diseases in the country. Lack of physical activity, obese population, alcohol consumption, unhealthy diet, and smoking are some major factors leading to the rising number of incidences of these conditions. The rising aging population may further increase the risk of hypertension in China. With the age, arteries get stiffer and thereby blood pressure goes up. Apart from the aging population, the condition has been shown to increase among adults in the country. As per the findings by the researchers at Yale and the Chinese National Center for Cardiovascular Disease published in October 2017, over one-third of adults in China are suffering from high blood pressure. Hypertension raised the risk of severe health problems, such as heart attack and stroke. The use of indapamide supports to reduce the blood pressure and the risk of having other severe condition among patients. Request a free sample of our report on China Indapamide Market: https://www.omrglobal.com/request-sample/china-indapamide-market China indapamide market is segmented on the basis of product and application. Based on the product, the market is bifurcated into 1.25 mg indapamide and 2.5 mg indapamide. Among these, the market for 1.25 mg indapamide held a significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have a significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions. A full report of China Indapamide Market Is available at Global Anti-Acne https://www.omrglobal.com/industry-reports/china-indapamide-market China Indapamide Market Segmentation By Product

  3. 1.25 MG 2.5 MG By Application High Blood Pressure Heart Failure Others Company Profiles ANI Pharmaceuticals, Inc. Glenmark Pharmaceuticals Ltd. Merck KGaA Sandoz International GmbH Sanofi S.A. Shandong Yinfeida Pharmaceutical Co., Ltd. Supra Chemicals Suzhou Lixin Pharmaceutical Co., Ltd. Taj Pharmaceuticals Ltd. Torrent Pharmaceuticals Ltd. For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-indapamide-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated

  4. research reports, customized research reports, consulting, and other research- based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related